Proposal process overhaul for a global clinical research organization
A high-growth clinical research organization (CRO) executing clinical trials for pharmaceutical companies was experiencing a significant decline in proposal win rates for early phase drug trials. Feedback from clients indicated that proposal pricing could be 50%-300% higher than competitors in some situations. Lacking clear reasons for why competitiveness had slipped, and with little organizational-wide agreement about how to address the issue of regaining competitiveness, the CRO enlisted WP&C for help.
The decrease in early phase clinical trial win rates put revenue and profitability at risk and threatened the company’s longer-term growth as trial sponsors build experience and relationships with a CRO during early phase trials and often look to continue the relationship into later phase trials—which are more extensive and profitable.
The CRO lacked actionable competitive information to substantiate strategy for opportunities and was unable to easily compare bids and project plans from one proposal to another. Adding to the challenge, the company approached proposal development with a bottoms-up approach, which led each functional area to independently—and in isolation—create its portion of the overall proposal.
This approach often led to duplication of proposed activities and resources as well as the incorporation of services not specifically requested by sponsors. Our client needed to reliably benchmark and compare proposals before final submission, and needed to move towards a top-down proposal process where the functional areas worked in partnership to develop an appropriately scoped proposal at a competitive and profitable price.
With a strong understanding of clinical research organizations and the pharmaceutical industry, WP&C quickly evaluated the current state of our client’s proposal and bidding process. Our approach to improving the competitiveness of its proposals centered on three key areas:
After our evaluation of the CRO’s proposal and pricing process, WP&C recommended the client use the newly developed tool to pull together existing but dis-aggregated information from past proposals and the enterprise-wide customer relationship management tool to provided actionable information for future proposals.
Additionally, WP&C recommended a shift from the bottom-up to a top-down pricing model that required collaboration between functional area leaders across the business to develop competitive project bids. Lastly, we recommended and developed training and users’ guides to accompany the rollout and integration of the Benchmarking Tool into the proposal development process.
New business development and capture is core to every company’s strategy. In a period of only a few weeks, WP&C assisted senior client executives in developing and successfully implementing a new proposal and pricing strategy, and significantly shifted the thinking of business leaders across functional areas.
The decrease in early phase clinical trial win rates put revenue and profitability at risk and threatened the company’s longer-term growth as trial sponsors build experience and relationships with a CRO during early phase trials and often look to continue the relationship into later phase trials—which are more extensive and profitable.
The CRO lacked actionable competitive information to substantiate strategy for opportunities and was unable to easily compare bids and project plans from one proposal to another. Adding to the challenge, the company approached proposal development with a bottoms-up approach, which led each functional area to independently—and in isolation—create its portion of the overall proposal.
This approach often led to duplication of proposed activities and resources as well as the incorporation of services not specifically requested by sponsors. Our client needed to reliably benchmark and compare proposals before final submission, and needed to move towards a top-down proposal process where the functional areas worked in partnership to develop an appropriately scoped proposal at a competitive and profitable price.
With a strong understanding of clinical research organizations and the pharmaceutical industry, WP&C quickly evaluated the current state of our client’s proposal and bidding process. Our approach to improving the competitiveness of its proposals centered on three key areas:
After our evaluation of the CRO’s proposal and pricing process, WP&C recommended the client use the newly developed tool to pull together existing but dis-aggregated information from past proposals and the enterprise-wide customer relationship management tool to provided actionable information for future proposals.
Additionally, WP&C recommended a shift from the bottom-up to a top-down pricing model that required collaboration between functional area leaders across the business to develop competitive project bids. Lastly, we recommended and developed training and users’ guides to accompany the rollout and integration of the Benchmarking Tool into the proposal development process.
New business development and capture is core to every company’s strategy. In a period of only a few weeks, WP&C assisted senior client executives in developing and successfully implementing a new proposal and pricing strategy, and significantly shifted the thinking of business leaders across functional areas.